Trials / Recruiting
RecruitingNCT05559853
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
Development of a Clinical CEST MR Fingerprinting Method for Treatment Response Assessment in Brain Metastases
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 119 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to develop and test a new magnetic resonance imaging (MRI) technique to see if it can be used to tell the difference between tumor growth from worsening of cancer and growth from the effects of treatment in participants who have brain tumors treated with radiation therapy called stereotactic radiosurgery (SRS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | CEST-MRF | CEST-MRF enables accurate quantification of both proton exchange rates and volume fractions in a fraction of the time required by conventional pulse sequences will be developed and optimized. |
Timeline
- Start date
- 2022-09-22
- Primary completion
- 2027-09-22
- Completion
- 2027-09-22
- First posted
- 2022-09-29
- Last updated
- 2026-03-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05559853. Inclusion in this directory is not an endorsement.